| Nov 20 |
Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal
|
| Nov 19 |
3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
|
| Nov 19 |
HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
|
| Nov 19 |
Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now?
|
| Nov 19 |
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
|
| Nov 18 |
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
|
| Nov 17 |
Halozyme plans to finance $2.1B takeover of Evotech in cash: report
|
| Nov 17 |
Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says
|
| Nov 15 |
Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer
|
| Nov 15 |
Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
|
